Target intelligence / Profile preview

Protocadherin alpha-7 (PCDHA7)

Target
PCDHA7
Molecular classification
Cell adhesion molecule, Cadherin superfamily, Protocadherin family, Clustered protocadherin (alpha cluster), Integral membrane protein
01

Overview

Protocadherin alpha-7 (PCDHA7) is a member of the protocadherin alpha gene cluster within the cadherin superfamily, encoding a neural cell-adhesion protein embedded in the plasma membrane. It mediates calcium-dependent homophilic cell-cell adhesion and is primarily expressed in the brain, where it is thought to play a crucial role in establishing and maintaining specific neuronal connections and enabling neuronal self-recognition and discrimination between self and non-self. This may create unique cell-surface identities for individual neurons, essential for proper neural circuit assembly. Structural features include six extracellular cadherin repeats and a cytoplasmic domain encoded by cluster-shared constant exons. Genetic variation in PCDHA7 is associated with neurodevelopmental disorders, especially autism spectrum disorder. No drugs are directly known to target PCDHA7, and its function is mainly structural and organizational rather than enzymatic or signal-transducing in the classical pharmacological sense.

Other names
CNR4CNRN4CNRS4CRNR4PCDH-ALPHA7PCDH-alpha-7KIAA0345-like 7ortholog to mouse CNR4Protocadherin alpha 7
02

Biological functions

Cell-cell adhesionNeuronal self-recognitionEstablishment and maintenance of specific neuronal connectionsCalcium-dependent homophilic binding
03

Disease associations

Autism spectrum disorderProstate cancerNeurodevelopmental disorders
04

Biomarkers

Variants/SNPs in PCDHA7 (e.g., rs251379, rs1119032, rs17119271, rs155806, rs17119346) as risk modifiers for autism spectrum disorder

Beyond the preview

Go deeper on Protocadherin alpha-7 (PCDHA7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protocadherin alpha-7 (PCDHA7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call